Lineage Cell Therapeutics expected to be added to Russell 3000® index.
false
ליניאג' סל תרפיוטיקס אינק
2
380
.LINEAGE CELL THERAPEUTICS, INC
Corporation no:
876343
10834
Israel Securities Authority
Tel Aviv Stock Exchange
C002
(
Public
)
Reported via MAGNA:
22/05/2023
www.isa.gov.il
www.tase.co.il
Reference:
2023-02-054531
Time of broadcast:
15:51
15:51
Immediate Report
Regulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
Lineage Cell Therapeutics expected to be added to Russell 3000® index.
LCT_Russell_22-05-2023_isa.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Stock Exchange/Market:
-1
Date of revision of form structure:
02/05/2023
Address:
HARBOR BAY PARKWAY
1301
,
ALAMEDA
94502
CALIFORNIA
,
U.S.A
Tel:
5105213390
,
Fax:
5105213389
E-mail address:
info@biotimeinc.com
Company site:
biotimeinc.com
Previous names of reporting entity:
.BIOTIME, INC
Name of the Signatory:
Gerzi Ilan
Position of Signatory in the reporting corporation:
Attorney/Legal Counsel
Name of Employer Company:
PEARL COHEN ZEDEK LATZER BARATZ
Address:
Derech Menachem Begin
132
,
Tel-Aviv
6702101
Telephone:
03-6073777
Facsimile:
03-6073778
E-mail:
Igerzi@pearlcohen.com
1
U.S.A